Mohamed is a principal scientist at the Predictive, Investigative and Translational Toxicology department, Preclinical Sciences and Translational Safety (PSTS) of Janssen R&D in Beerse. He started as a postdoc scientist at Janssen in 2016 within the same group, where his role was to develop in vitro neurotoxicity assays as alternatives to animal use (3Rs: Refine, Reduce, and Replace the use of animals). Prior to his postdoc, Mohamed obtained his PhD in Pharmacology at the Jacob University Bremen in Germany in 2010 before joining a small biotech company in Munich. After his postdoc, he obtained a full position as a senior scientist in 2019 and became a principal scientist in 2022.
Mohamed is a principal scientist at the Predictive, Investigative and Translational Toxicology department, Preclinical Sciences and Translational Safety (PSTS) of Janssen R&D in Beerse. He started as a postdoc scientist at Janssen in 2016 within the same group, where his role was to develop in vitro neurotoxicity assays as alternatives to animal use (3Rs: Refine, Reduce, and Replace the use of animals). Prior to his postdoc, Mohamed obtained his PhD in Pharmacology at the Jacob University Bremen in Germany in 2010 before joining a small biotech company in Munich. After his postdoc, he obtained a full position as a senior scientist in 2019 and became a principal scientist in 2022.